Home / Learn / Conditions

Conditions

Dry mouth in neurological disease: practical relief and treatment options

How ALS, multiple sclerosis, Parkinson’s disease and stroke can reduce saliva, and how a long-lasting lipid-based spray compares with other options.

Dry mouth (xerostomia) is a frequent but under-recognised problem in many neurological conditions, and it can make chewing, swallowing, speaking and everyday oral care difficult. This article explains how neurological injury and common medications disrupt saliva production, then lays out practical treatment pathways (topical, systemic and device-based) so you and your care team can choose the best approach. You’ll see how disorders such as ALS, multiple sclerosis, Parkinson’s disease and stroke reduce saliva, why lipid-based films matter, and how Aquoral’s lipid film works in practice.

Why neurological diseases cause dry mouth

When the nerve control of the salivary glands is disturbed, by central or peripheral nerve injury, by a drop in gland output, or by medications that block cholinergic signalling, saliva production falls. Reduced nerve signalling diminishes both reflex and resting saliva, producing persistent dryness that impairs lubrication and clearing of the mouth. Over time, reduced use or chronic autonomic imbalance can further weaken gland function.

The main neurological contributors are:

  • Disrupted nerve signalling from central or peripheral nervous system damage that blunts salivary reflexes.
  • Medication effects, notably drugs with anticholinergic properties that reduce gland output.
  • Local salivary gland dysfunction or decreased oral activity leading to lower baseline secretion.

Each cause points to a different priority: local lubrication, systemic stimulation or device-assisted therapy.

Although this piece focuses on neurological causes, other conditions also produce dry mouth. For example, autoimmune disease such as Sjögren’s is a frequent source of chronic xerostomia and calls for specialised management.

How conditions like ALS and MS lead to xerostomia

In amyotrophic lateral sclerosis (ALS), progressive motor neuron loss weakens chewing and swallowing, reducing oral stimulation and clearance and often making the mouth feel drier. In multiple sclerosis (MS), demyelination and autonomic dysfunction interrupt the nerve pathways that regulate the salivary glands, producing intermittent or persistent dryness. Both make oral tissues more vulnerable to injury, so even modest saliva reductions can have a large impact. This is why protective, longer-acting topical options are useful when saliva-stimulating medicines are less suitable.

How medications and gland dysfunction contribute

Many drugs used in neurology, including those with anticholinergic effects, dopaminergic therapies and some antispasmodics, can reduce saliva and worsen xerostomia. Chronic inactivity or inflammation can also cause the glands to shrink or produce less, so topical protection may be needed even when stimulants are considered. Telling medication-driven dryness apart from primary gland disease is important; your doctor can help decide whether to adjust medicines or add local protection. Never stop or change a medication without talking to your doctor.

How Aquoral works for neurological dry mouth

Aquoral is a lipid-based spray, available without a prescription in Canada, that uses Oxidized Glycerol Triesters (OGT) to form a thin, protective film over oral tissues. This lipid layer lubricates the lining of the mouth and helps retain moisture for extended periods, commonly reported as four to six hours, offering longer relief than water-based substitutes. That durability is particularly useful in neurological dry mouth, where avoiding frequent reapplication and protecting the tissues are priorities.

  • Active ingredient: Oxidized Glycerol Triesters (OGT), which create a protective lipid film on the lining of the mouth.
  • Formulation: a lipid-based spray for durable lubrication and better moisture retention.
  • Typical duration: 4 to 6 hours, meaning fewer daily applications and sustained protection.

For people with neurological conditions, this means simpler routines, less need for frequent reapplication, and a protective barrier that supports chewing and swallowing.

How Aquoral’s lipid film works

Aquoral’s Oxidized Glycerol Triesters spread across the lining of the mouth to form a thin, water-repelling layer that adheres to the surface and reduces moisture loss. The barrier lubricates tissues, helps form food into a ball for swallowing, and reduces friction during chewing and swallowing. Because the film preserves existing moisture rather than stimulating more saliva, it avoids body-wide cholinergic effects and shields tissues from friction and drying. In practice, that means more comfortable eating and speaking with fewer interruptions.

Why Aquoral provides longer-lasting relief than other options

Lipid-based sprays create an adherent barrier that typically holds moisture longer than water-based substitutes, which evaporate or wash away. Because the effect is local, lipid films avoid body-wide cholinergic stimulation and its side effects. For people who can’t tolerate saliva-stimulating medicines or who already take several neurological medications, a topical lipid film offers targeted symptom control without changing other treatment.

Which neurological conditions benefit most?

Lipid sprays are particularly valuable when nerve control, dexterity or swallowing are impaired and lasting protection improves function and comfort. Dry mouth occurs frequently in motor neuron diseases, demyelinating disorders, movement disorders and after stroke. Topical lipid films are best when the main need is lubrication and protection rather than stimulating the salivary glands.

  • ALS: motor neuron loss reduces natural lubrication and clearance; long-lasting lubrication supports swallowing and speech.
  • Multiple sclerosis: demyelination and autonomic dysfunction cause variable saliva; a predictable topical film gives consistent protection during eating and speaking.
  • Parkinson’s disease: medication effects and motor symptoms create alternating drooling and dryness; the film reduces friction and improves comfort around meals.
  • Stroke-related swallowing problems: swallowing impairment and one-sided weakness make frequent reapplication difficult; a longer-lasting film reduces how often it’s needed, supports safer swallowing and eases caregiver burden.

How to use Aquoral in ALS and MS

In ALS and MS, timing is key: apply before meals, long conversations or at night to make the most of function and protect the mouth. Caregivers can help people with limited dexterity by holding the spray and making sure the surfaces of the mouth are evenly covered so the film forms properly. Use it as symptoms need, alongside routine oral hygiene to reduce dental problems; the longer-lasting film means caregivers need to step in less often. A speech-language pathologist or your care team can help fit it into a broader swallowing and oral-care plan.

Benefits for Parkinson’s disease and stroke-related dry mouth

For Parkinson’s disease, where motor symptoms and medications interact, a topical lipid film provides local relief without changing other treatment. For stroke survivors with one-sided weakness or swallowing difficulty, the spray’s extended action reduces the burden of frequent application and can be applied by caregivers on the affected side. The film also protects against abrasion and supports oral hygiene, both important for preventing tooth decay and soreness.

What treatment options are there for dry mouth from neurological disorders?

Options include saliva-stimulating medicines, topical lipid sprays, water-based saliva substitutes and device-based approaches; the choice depends on the underlying cause, other health conditions and your goals. Saliva-stimulating medicines boost gland output and work when the glands still have capacity, but they can cause body-wide side effects that are problematic for people with neurological conditions. Topical lipid sprays deliver local protection with longer duration and no body-wide exposure. Device-based or behavioural approaches can complement either.

  • Saliva-stimulating medicines: increase gland secretion through cholinergic pathways; act throughout the body; duration varies and side effects are possible.
  • Topical lipid sprays: form a protective lipid film on the lining of the mouth; act locally; about 4 to 6 hours, with fewer body-wide effects.
  • Water-based saliva substitutes: temporarily replace moisture; act locally; short duration and frequent reapplication.
  • Electrostimulation devices: stimulate the glands with electrical impulses; require device use and have their own limitations.

Beyond neurological causes, other serious health issues, for example cancer treatment, can produce severe, persistent dry mouth.

How Aquoral compares with pilocarpine and cevimeline

Pilocarpine and cevimeline increase saliva by activating cholinergic receptors throughout the body. Aquoral’s lipid film works topically to preserve moisture and protect the mouth without acting on the rest of the body. That difference affects side effects and who each option suits: topical films suit people who can’t tolerate systemic medicines or who mainly need protection for the mouth. In many neurological care plans, predictable relief with minimal interaction with other medicines is decisive. See pilocarpine side effects and alternatives.

Dry mouth also arises from environmental and device-related causes. For instance, CPAP-related dry mouth is common among people using positive airway pressure therapy. Lifestyle factors can contribute too; people with cannabis-related dry mouth often find topical sprays provide meaningful relief.

When to choose a lipid-based spray over other products

Consider a long-lasting lipid-based spray when symptoms persist despite water-based products, when there is tissue injury or recurring dental disease, when saliva-stimulating medicines aren’t suitable or poorly tolerated, or when limited dexterity makes frequent applications difficult.

  • Persistent dry mouth despite water-based products
  • Signs of tissue injury or recurring dental problems
  • Medicines that stimulate saliva aren’t suitable or cause side effects
  • A need for lasting lubrication with fewer daily applications

Raise dry mouth at your regular neurology or dental appointments so your care team can check your mouth and help build a plan that includes the right relief for you.

Order Aquoral

This article is general information and does not replace advice from your health professional. Content adapted for Canada; pending review.